{"id":"https://openalex.org/W2069779346","doi":"https://doi.org/10.1002/jps.20725","title":"In Situ Measurement of Solvent-Mediated Phase Transformations During Dissolution Testing","display_name":"In Situ Measurement of Solvent-Mediated Phase Transformations During Dissolution Testing","publication_year":2006,"publication_date":"2006-08-05","ids":{"openalex":"https://openalex.org/W2069779346","doi":"https://doi.org/10.1002/jps.20725","mag":"2069779346","pmid":"https://pubmed.ncbi.nlm.nih.gov/16892206"},"language":"en","primary_location":{"id":"doi:10.1002/jps.20725","doi":"https://doi.org/10.1002/jps.20725","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jps.20725","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041086762","display_name":"Jaakko Aaltonen","orcid":"https://orcid.org/0000-0003-2954-2674","observed_orcids":["https://orcid.org/0000-0003-2954-2674"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":true,"raw_author_name":"Jaakko Aaltonen","raw_affiliation_strings":["Division of Pharmaceutical Technology, P.O. Box 56, 00014 University of Helsinki, Finland. jaakko.aaltonen@helsinki.fi","Division of Pharmaceutical Technology, P.O. Box 56, 00014 University of Helsinki, Finland","Drug Discovery and Development Technology Center, P.O. Box 56, 00014 University of Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutical Technology, P.O. Box 56, 00014 University of Helsinki, Finland. jaakko.aaltonen@helsinki.fi","institution_ids":["https://openalex.org/I133731052"]},{"raw_affiliation_string":"Division of Pharmaceutical Technology, P.O. Box 56, 00014 University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]},{"raw_affiliation_string":"Drug Discovery and Development Technology Center, P.O. Box 56, 00014 University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082887314","display_name":"Paula Hein\u00e4nen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Paula Hein\u00e4nen","raw_affiliation_strings":["Orion Pharma, P.O. Box 65, 02101 Espoo, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orion Pharma, P.O. Box 65, 02101 Espoo, Finland","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Leena Peltonen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Leena Peltonen","raw_affiliation_strings":["Division of Pharmaceutical Technology, P.O. Box 56, 00014 University of Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutical Technology, P.O. Box 56, 00014 University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111858259","display_name":"Hanna Kortej\u00e4rvi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Hanna Kortej\u00e4rvi","raw_affiliation_strings":["Orion Pharma, P.O. Box 65, 02101 Espoo, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orion Pharma, P.O. Box 65, 02101 Espoo, Finland","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079592754","display_name":"Veli Pekka Tanninen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118237","display_name":"Orion Corporation (Finland)","ror":"https://ror.org/0296s4x19","country_code":"FI","type":"company","lineage":["https://openalex.org/I4210118237"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Veli Pekka Tanninen","raw_affiliation_strings":["Orion Pharma, P.O. Box 65, 02101 Espoo, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Orion Pharma, P.O. Box 65, 02101 Espoo, Finland","institution_ids":["https://openalex.org/I4210118237"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006657459","display_name":"Leena Christiansen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Leena Christiansen","raw_affiliation_strings":["Division of Pharmaceutical Technology, P.O. Box 56, 00014 University of Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutical Technology, P.O. Box 56, 00014 University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024426748","display_name":"Jouni J. Hirvonen","orcid":"https://orcid.org/0000-0002-5029-1657","observed_orcids":["https://orcid.org/0000-0002-5029-1657"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Jouni Hirvonen","raw_affiliation_strings":["Division of Pharmaceutical Technology, P.O. Box 56, 00014 University of Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutical Technology, P.O. Box 56, 00014 University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081473490","display_name":"Jouko K. Yliruusi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Jouko Yliruusi","raw_affiliation_strings":["Division of Pharmaceutical Technology, P.O. Box 56, 00014 University of Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pharmaceutical Technology, P.O. Box 56, 00014 University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021353433","display_name":"Jukka Rantanen","orcid":"https://orcid.org/0000-0002-8211-5607","observed_orcids":["https://orcid.org/0000-0002-8211-5607"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"Jukka Rantanen","raw_affiliation_strings":["Department of Pharmaceutics and Analytical Chemistry, Universitetsparken 2, The Danish University of Pharmaceutical Sciences, 2100 Copenhagen, Denmark","Drug Discovery and Development Technology Center, P.O. Box 56, 00014 University of Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutics and Analytical Chemistry, Universitetsparken 2, The Danish University of Pharmaceutical Sciences, 2100 Copenhagen, Denmark","institution_ids":[]},{"raw_affiliation_string":"Drug Discovery and Development Technology Center, P.O. Box 56, 00014 University of Helsinki, Finland","institution_ids":["https://openalex.org/I133731052"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5041086762"],"corresponding_institution_ids":["https://openalex.org/I133731052"],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":4.6112,"has_fulltext":false,"cited_by_count":99,"citation_normalized_percentile":{"value":0.95620451,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"95","issue":"12","first_page":"2730","last_page":"2737"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.850600004196167,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.850600004196167,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.14560000598430634,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12358","display_name":"Thermal and Kinetic Analysis","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/theophylline","display_name":"theophylline","score":0.8569999933242798},{"id":"https://openalex.org/keywords/nitrofurantoin","display_name":"nitrofurantoin","score":1.0},{"id":"https://openalex.org/keywords/dissolution-testing","display_name":"dissolution testing","score":0.578000009059906},{"id":"https://openalex.org/keywords/solid-state-forms","display_name":"solid forms","score":0.6610000133514404},{"id":"https://openalex.org/keywords/dissolution-rate","display_name":"dissolution rate","score":0.8650000095367432},{"id":"https://openalex.org/keywords/microcrystalline-cellulose","display_name":"microcrystalline cellulose","score":0.9559999704360962},{"id":"https://openalex.org/keywords/in-situ-raman-spectroscopy","display_name":"in situ Raman spectroscopy","score":0.796999990940094}],"concepts":[{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.8042783737182617},{"id":"https://openalex.org/C2777822432","wikidata":"https://www.wikidata.org/wiki/Q216681","display_name":"In situ","level":2,"score":0.7624136805534363},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.5549335479736328},{"id":"https://openalex.org/C2780471494","wikidata":"https://www.wikidata.org/wiki/Q146505","display_name":"Solvent","level":2,"score":0.5351736545562744},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.41750410199165344},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.3471326231956482},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.15495991706848145}],"mesh":[{"descriptor_ui":"D008855","descriptor_name":"Microscopy, Electron, Scanning","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009582","descriptor_name":"Nitrofurantoin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D009582","descriptor_name":"Nitrofurantoin","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013056","descriptor_name":"Spectrophotometry, Ultraviolet","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013059","descriptor_name":"Spectrum Analysis, Raman","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013806","descriptor_name":"Theophylline","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D013806","descriptor_name":"Theophylline","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D014867","descriptor_name":"Water","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D014961","descriptor_name":"X-Ray Diffraction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/jps.20725","doi":"https://doi.org/10.1002/jps.20725","is_oa":false,"landing_page_url":"https://doi.org/10.1002/jps.20725","pdf_url":null,"source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:16892206","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16892206","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical sciences","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/24f3e7fe-ef90-4d4d-b77d-c4596e744d83","doi":null,"is_oa":false,"landing_page_url":"https://researchprofiles.ku.dk/da/publications/24f3e7fe-ef90-4d4d-b77d-c4596e744d83","pdf_url":null,"source":{"id":"https://openalex.org/S4306401983","display_name":"Research at the University of Copenhagen (University of Copenhagen)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I124055696","host_organization_name":"University of Copenhagen","host_organization_lineage":["https://openalex.org/I124055696"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Aaltonen, J, Hein\u00e4nen, P, Peltonen, L, Kortej\u00e4rvi, H, Tanninen, V P, Christiansen, L, Hirvonen, J, Yliruusi, J & Rantanen, J 2006, 'In situ measurement of solvent-mediated phase transformations during dissolution testing', Journal of Pharmaceutical Sciences, vol. 95, no. 12, pp. 2730-7. https://doi.org/10.1002/jps.20725","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W37191436","https://openalex.org/W1581483950","https://openalex.org/W1971789585","https://openalex.org/W1973009939","https://openalex.org/W1988609629","https://openalex.org/W1991957603","https://openalex.org/W1994821056","https://openalex.org/W1996315753","https://openalex.org/W2002880551","https://openalex.org/W2019648099","https://openalex.org/W2020550842","https://openalex.org/W2028311340","https://openalex.org/W2028374531","https://openalex.org/W2031108716","https://openalex.org/W2034205145","https://openalex.org/W2039978520","https://openalex.org/W2041282152","https://openalex.org/W2048993566","https://openalex.org/W2049822555","https://openalex.org/W2052081265","https://openalex.org/W2057448579","https://openalex.org/W2076959999","https://openalex.org/W2121072761","https://openalex.org/W2519564259","https://openalex.org/W2937357360","https://openalex.org/W4285674535","https://openalex.org/W6726905352"],"related_works":["https://openalex.org/W2055915634","https://openalex.org/W2117007009","https://openalex.org/W758966922","https://openalex.org/W2236087015","https://openalex.org/W2076959999","https://openalex.org/W2000071394","https://openalex.org/W2105774612","https://openalex.org/W1528411849","https://openalex.org/W2091564143","https://openalex.org/W37191436"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}